Full-Time

Research Scientist

Posted on 7/19/2023

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Accelerates antibody drug discovery with data science

Data & Analytics
AI & Machine Learning
Biotechnology

Senior

Vancouver, BC, Canada

Required Skills
Communications
Requirements
  • You enjoy a fast-paced work environment and take pride in being highly self-motivated
  • You are a creative problem solver who believes in teamwork to tackle the most challenging problems
  • You are comfortable working independently to identify project needs, and thrive on collaboratively constructing and implementing solutions
  • PhD in a relevant field, or a MSc with at least 5 years work experience in an industrial or academic wet lab environment
  • Demonstrated expertise with assay qualification and process optimization
  • Experience with preclinical R&D of immuno-oncology therapeutics
  • Experience with nonclinical development of large molecules/biologics from discovery to mid-stage development
  • Experience with authoring/reviewing experimental protocols and reports to ensure appropriate datasets are accurately generated and interpreted
  • Exceptional analytical and problem-solving capabilities
  • Excellent documentation, organizational and communication skills
  • Strong interpersonal skills with the ability to work collaboratively as a member of a cross-functional team
Desired Qualifications
  • Experience with assessing new and emerging molecular or imaging techniques for biospecimen analysis

AbCellera stands out as a leader in the biotech industry due to its unique approach to antibody drug discovery, combining expert teams, advanced technology, and data science to expedite the process from target to clinic across various therapeutic areas. The company's competitive edge lies in its ability to enable swift progress, cost reduction, and problem-solving in drug development for both innovative biotechs and leading pharmaceutical companies. Furthermore, AbCellera's commitment to technical innovation is evident in its recent presentation of new data on two T-Cell Engager Programs at SITC 2023, demonstrating its active role in advancing the field.

Company Stage

Series A

Total Funding

$393.1M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

16%

2 year growth

77%
INACTIVE